Stockholders' Deficiency (Details) - Warrant [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of warrants, balance, beginning of year | 243,323,017 | |
| Weighted average exercise price, beginning of year | $ 0.021 | |
| Weighted average life excercised (in years) | 1 year 3 months 18 days | 2 years 18 days |
| Weighted average grant date fair value, beginning of period | $ 1,963,079 | |
| Number of warrants, expired | ||
| Number of warrants, balance, end of period | 243,323,017 | 243,323,017 |
| Weighted average exercise price, ending of year | $ 0.021 | $ 0.021 |
| Weighted average grant date fair value, end of period | $ 1,963,079 | $ 1,963,079 |
| X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award non options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award non options outstanding weighted grant date fair value. No definition available.
|
| X | ||||||||||
- Definition The element represents sharebased compensation arrangement by sharebased payment award non options issued weighted average remaining excerisable contractual term2. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|